Melissa B, Epperly
Director at Roivant Sciences Ltd. (ROIV)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 5SEC | ROIVRoivant Sciences Ltd. | Sell Plan | 16,85015,854 held (−52%) | $36.08 | $608K | -1.8% |
| Oct 5SEC | ROIVRoivant Sciences Ltd. | Sell Plan | 90014,954 held (−6%) | $36.57 | $33K | -3.1% |
| Sep 17SEC | ROIVRoivant Sciences Ltd. | Sell Plan | 4,33810,500 held (−29%) | $39.65 | $172K | -10.6% |
| Sep 17SEC | ROIVRoivant Sciences Ltd. | Sell Plan | 6009,900 held (−6%) | $40.38 | $24K | -12.2% |
| Jul 1SEC | ROIVRoivant Sciences Ltd. | Sell Plan | 15,00219,222 held (−44%) | $34.32 | $515K | +3.3% |
| Jul 1SEC | ROIVRoivant Sciences Ltd. | Sell Plan | 2,74816,474 held (−14%) | $34.71 | $95K | +2.1% |
| Mar 18SEC | ROIVRoivant Sciences Ltd. | Sell | 41,86115,804 held (−73%) | $28.68 | $1.2M | +23.6% |
- Sell
Director Melissa B, Epperly sold $608K of ROIV at $36.08 — cuts the stake by 52%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Melissa B, Epperly sold $33K of ROIV at $36.57 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Melissa B, Epperly sold $172K of ROIV at $39.65 — cuts the stake by 29%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Melissa B, Epperly sold $24K of ROIV at $40.38 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Melissa B, Epperly sold $515K of ROIV at $34.32 — cuts the stake by 44%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Melissa B, Epperly sold $95K of ROIV at $34.71 — pre-scheduled 10b5-1 plan sale.